Clinical Trial Update: Romiplostim N01 for Platelet Recovery in Adult Hematologic Malignancies Patients Undergoing UCBT [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating romiplostim (N01) to improve platelet recovery in adults with hematologic malignancies undergoing umbilical cord blood trans…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hematologic Malignancies

Drugs mentioned

• Romiplostim N01 (romiplostim)

Snippet

Sponsor: Anhui Provincial Hospital | Conditions: Platelet Recovery After Umbilical Cord Blood Transplantation | Phase 2 | Status: RECRUITING